1.Diagnosis and Management of Peptic Ulcer Bleeding.
Korean Journal of Medicine 2015;88(2):156-160
Despite the generally declining trend in the incidence of peptic ulcers, peptic ulcer bleeding remains a prevalent and clinically significant condition. Additionally, despite the development of therapeutic endoscopy and acid-suppressive therapy, the overall mortality associated with peptic ulcer bleeding has remained at about 6% to 14%. Management of acute peptic ulcer bleeding requires prompt resuscitation, risk assessment, early endoscopic evaluation, and early initiation of pharmacotherapy. Advances in therapeutic endoscopic techniques and antisecretory therapies in the past few decades have reduced the incidence of recurrent bleeding and the mortality rate associated with this disease. Strategies to prevent recurrence have been defined for various causes of peptic ulcer bleeding. This article reviews the current diagnosis and management of acute peptic ulcer bleeding.
Diagnosis*
;
Disease Management
;
Drug Therapy
;
Endoscopy
;
Hemorrhage*
;
Incidence
;
Mortality
;
Peptic Ulcer Hemorrhage
;
Peptic Ulcer*
;
Recurrence
;
Resuscitation
;
Risk Assessment
2.Guidelines of Treatment for Bleeding Peptic Ulcer Disease.
Il Kwun CHUNG ; Dong Ho LEE ; Heung Up KIM ; In Kyung SUNG ; Jin Ho KIM
The Korean Journal of Gastroenterology 2009;54(5):298-308
Peptic ulcer (PU) bleeding is the main cause of non-variceal gastrointestinal bleeding. Negative outcomes include re-bleeding and death, and many of the deaths are associated with decompensation of coexisting medical conditions precipitated by acute bleeding event. Accurate analysis of risk for clinical features can help physician to decide treatment modality. Endoscopy can detect bleeding stigmata and perform therapeutic hemostasis. Proton pump inhibitor (PPI) compared with placebo or H2RA reduces mortality following PU bleeding among patients with high-risk endoscopic findings, and reduces re-bleeding rates and surgical intervention. PPI treatment initiated prior to endoscopy in upper gastrointestinal (UGI) bleeding significantly reduces the proportion of patients with stigmata of recent hemorrhage (SRH) at index endoscopy but does not reduce mortality, re-bleeding or the need for surgery. The strategy of giving oral PPI before and after endoscopy, with endoscopic hemostasis for those with major SRH, is likely to be the most cost-effective. The treatment of H. pyori infection was found to be more effective than anti-secretory therapy in preventing recurrent bleeding from PU. H. pyori eradication alone and eradication followed by misoprostol (with switch to PPI, if misoprostol is not tolerated) are the two most cost-effective strategies to prevent ulcer bleeding among H. pyori-infected NSAID users, although the data cannot exclude PPIs also being cost-effective treatment. This review focuses specifically on the current treatment of patients with acute bleeding from a peptic ulcer.
Anti-Ulcer Agents/therapeutic use
;
Endoscopy, Gastrointestinal
;
Gastrointestinal Hemorrhage/diagnosis
;
Helicobacter Infections/diagnosis/drug therapy
;
Helicobacter pylori
;
Hemostasis, Endoscopic
;
Humans
;
Misoprostol/therapeutic use
;
Peptic Ulcer/surgery/*therapy
;
Peptic Ulcer Hemorrhage/surgery/*therapy
;
Proton Pump Inhibitors/therapeutic use
3.Massive Gastric Ulcer Bleeding in a Healthy Full Term Infant.
Young Sil PARK ; Woo Chul CHUNG ; Kang Moon LEE ; Bo In LEE ; Ji Sung CHUN ; U Im CHANG ; Jin Mo YANG ; Kyu Yong CHOI ; In Sik CHUNG
The Korean Journal of Gastroenterology 2006;48(3):210-214
Gastric ulcer bleeding in neonatal period, mainly in preterm newborn babies or in neonates treated in intensive care units, is relatively frequent, However the occurrence of significant gastric ulcer bleeding in healthy full term infants is unusual. We experienced a case of massive upper gastrointestinal (GI) bleeding in a 3-day-old healthy full term infant. Endoscopic examination confirmed the presence of gastric ulcerations. Treatment was initiated with transfusion and histamine 2 receptor antagonist, and the clinical signs resolved. Mother's serum antibody to Helicobacter pylori (H. pylori) was positive. We collected stool of the patient including other 17 infants in the intensive care unit. A highly sensitive semi-nested PCR for H. pylori DNA was performed, but all infants including the patient revealed negative. H. pylori infection is not related with upper GI bleeding in healthy full term infants. In conclusion, the diagnosis of upper GI bleeding in infant can be easily made by means of pediatric endoscopy, which is a simple and a well tolerated examination.
Blood Transfusion
;
Endoscopy, Gastrointestinal
;
Female
;
Histamine Antagonists/therapeutic use
;
Humans
;
Infant, Newborn
;
Peptic Ulcer Hemorrhage/*diagnosis/drug therapy/therapy
;
Stomach Ulcer/*complications
4.Current Status and Clinical Impact of Pediatric Endoscopy in Korea.
Yang Woon LEE ; Woo Chul CHUNG ; Hea Jung SUNG ; Yoon Goo KANG ; So Lim HONG ; Kang Won CHO ; Donghoon KANG ; In Hee LEE ; Eun Jung JEON
The Korean Journal of Gastroenterology 2014;64(6):333-339
BACKGROUND/AIMS: In pediatrics, endoscopic examination has become a common procedure for evaluation of gastrointestinal presentations. However, there are limited data on pediatric endoscopy in Korea. The aim of this study was to analyze the current status and clinical impacts of endoscopic examination in children and adolescents. METHODS: We retrospectively reviewed the medical records of outpatients who visited the tertiary hospital. Patients under 18 years of age who underwent endoscopy were included. Endoscopic findings were classified as specific and normal based on gross findings. Specific endoscopic findings were reflux esophagitis, peptic ulcers, and Mallory-Weiss tear. Other findings included acute gastritis classified according to the updated Sydney system. RESULTS: In 722 of 330,350 patients (0.2%), endoscopic examination (554 esophagogastroduodenoscopies [EGDs], 121 colonoscopies, 47 sigmoidoscopies) was performed between January 2008 and January 2013. In EGD, abdominal pain was the most frequent presentation (64.1%). The most common diagnosis was gastritis (53.2%), followed by reflux esophagitis. The frequency of peptic ulcer disease was 12.8%. Frequent symptoms leading to colonoscopic examination were abdominal pain, diarrhea, and hematochezia. In colonoscopy, a negative result was more likely in children younger than 7 years old. After the procedure, the diagnostic yield of EGD and colonoscopy was 88.1% and 45.8%, respectively, and the rate of change in management was 67.1%. CONCLUSIONS: In pediatrics, endoscopic examination was useful for the choice of therapeutic strategy and it would be a standard method for evaluation of gastrointestinal presentation.
Abdominal Pain
;
Adolescent
;
Child
;
Child, Preschool
;
*Endoscopy, Digestive System
;
Esophagitis, Peptic/diagnosis/drug therapy
;
Female
;
Gastritis/diagnosis/drug therapy
;
Gastrointestinal Hemorrhage/diagnosis
;
Histamine H2 Antagonists/therapeutic use
;
Humans
;
Infant
;
Infant, Newborn
;
Inflammatory Bowel Diseases/diagnosis
;
Male
;
Peptic Ulcer/diagnosis/drug therapy
;
Proton Pump Inhibitors/therapeutic use
;
Republic of Korea
;
Retrospective Studies
;
Tertiary Care Centers
5.Clinical Characteristics of Patients Diagnosed as Peptic Ulcer Disease in the Third Referral Center in 2007.
Jin Joo KIM ; Nayoung KIM ; Hyun Kyung PARK ; Hyun Jin JO ; Cheol Min SHIN ; Sang Hyup LEE ; Young Soo PARK ; Jin Hyeok HWANG ; Jin Wook KIM ; Sook Hyang JEONG ; Dong Ho LEE ; Jung Mogg KIM ; Ji Hyun LEE ; Hyun Chae JUNG ; In Sung SONG
The Korean Journal of Gastroenterology 2012;59(5):338-346
BACKGROUND/AIMS: In spite of the improvement of medical treatment for the peptic ulcer disease (PUD), PUD is still one of the common upper gastrointestinal diseases. The purpose of this study was to evaluate the risk factors and general characteristics of Korean patients diagnosed as PUD at a single third referral center. METHODS: A total of 310 patients, diagnosed as PUD through endoscopy during one year of 2007 at Seoul National University Bundang Hospital were, retrospectively, evaluated regarding age, gender, Helicobacter pylori (H. pylori) positivity, clinical manifestations, comorbidities and medications. In addition, PUD was analyzed in the aspect of ulcer location, type of visit, gastrointestinal bleeding, and age. RESULTS: The mean age was 61.5 years old (48.1% over 65) and 208 (66.7%) patients were men. The rate of H. pylori infection was 47.8%, and any ulcerogenic medication history such as antiplatelet agents and NSAIDs was found to be 21.0% (65 patients). The rate of idiopathic peptic ulcer without evidence of H. pylori and NSAIDs was found to be 40.6% (126 patients). Among 310 PUD patients, bleeding symptoms such as melena, hematemesis and hematochezia occurred in 110 patients (35.5%). CONCLUSIONS: PUD was more prevalent in the elderly patients and frequently associated with bleeding. Substantial proportion of PUD patients had neither H. pylori infection nor history of ulcerogenic medications, suggesting of increasing prevalence of idiopathic PUD.
Adult
;
Age Factors
;
Aged
;
Aged, 80 and over
;
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use
;
Female
;
Gastrointestinal Hemorrhage
;
Gastroscopy
;
Helicobacter Infections/complications/diagnosis
;
Helicobacter pylori
;
Hematemesis
;
Humans
;
Male
;
Melena
;
Middle Aged
;
Peptic Ulcer/*diagnosis/drug therapy/epidemiology
;
Platelet Aggregation Inhibitors/therapeutic use
;
Prevalence
;
Referral and Consultation
;
Retrospective Studies
;
Risk Factors
;
Sex Factors
6.Clinical Impact of Dual Antiplatelet Therapy on Peptic Ulcer Disease.
Dae Geon AHN ; Beom Jin KIM ; Jeong Wook KIM ; Jae Gyu KIM
The Korean Journal of Gastroenterology 2014;64(2):81-86
BACKGROUND/AIMS: Increased incidence of coronary artery disease has led to the increased use of dual antiplatelet therapy composed of aspirin and clopidogrel. We investigated the incidence of gastrointestinal complications in patients who received single or dual antiplatelet therapy and analyzed their clinical characteristics in order to predict the prognostic factors. METHODS: Between January 2009 and December 2011, we retrospectively reviewed the medical records of patients who underwent coronary angiography at Chung-Ang University Hospital (Seoul, Korea). One hundred and ninety-four patients were classified into two groups: aspirin alone group and dual antiplatelet group. Clinical characteristics, past medical history, and presence of peptic ulcer were analyzed. RESULTS: During the follow-up period, 11 patients had duodenal ulcer; the event rate was 2.02% in the aspirin alone group and 9.47% in the dual antiplatelet group (hazard ratio [HR] 5.24, 95% CI 1.03-26.55, p<0.05). There was no significant difference in the rate of significant upper gastrointestinal bleeding: 0% vs. 4.2% (p=0.78). In patients who received proton pump inhibitor (PPI), 24 patients had gastric ulcer; the event rate was significantly different between the two groups: 4.87% vs. 22.98% (HR 3.40, 95% CI 1.02-11.27, p<0.05). CONCLUSIONS: Dual antiplatelet groups had a higher incidence of duodenal ulcers without significant bleeding compared with the aspirin alone group. In patients who received PPI, the dual antiplatelet therapy group had a higher incidence of gastric ulcers without significant bleeding compared with the aspirin alone group. Therefore, physicians must pay attention to high risk groups who receive dual antiplatelet therapy and aggressive diagnostic endoscopy should also be considered.
Aged
;
Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use/toxicity
;
Aspirin/*therapeutic use/toxicity
;
Coronary Angiography
;
Coronary Artery Disease/*prevention & control
;
Drug Therapy, Combination
;
Female
;
Gastrointestinal Hemorrhage/chemically induced/prevention & control
;
Humans
;
Incidence
;
Male
;
Middle Aged
;
Peptic Ulcer/*diagnosis/epidemiology/etiology
;
Platelet Aggregation Inhibitors/*therapeutic use/toxicity
;
Proportional Hazards Models
;
Proton Pump Inhibitors/therapeutic use
;
Retrospective Studies
;
Risk Factors
;
Ticlopidine/*analogs & derivatives/therapeutic use/toxicity